Janus Henderson Group PLC Pacira Bio Sciences, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 23,319 shares of PCRX stock, worth $454,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,319

Previous 698,388 96.66%

Holding current value

$454,020

Previous $20 Million 98.24%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $7.9 Million - $19.2 Million	-675,069 Reduced 96.66%	23,319 $351,000
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $2.46 Million - $3.04 Million	96,328 Added 16.0%	698,388 $20 Million
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $54,652 - $70,002	-1,973 Reduced 0.33%	602,060 $17.6 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $1.75 Million - $2.28 Million	66,330 Added 12.34%	604,033 $20.4 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $5.63 Million - $7.36 Million	183,604 Added 51.85%	537,703 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $12.1 Million - $15.9 Million	334,292 Added 1687.75%	354,099 $14.2 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $389,977 - $476,138	10,976 Added 124.29%	19,807 $808,000
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $337,255 - $507,340	8,831 New	8,831 $340,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $819 - $942	16 Added 0.18%	8,830 $470,000
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $463 - $734	-9 Reduced 0.1%	8,814 $514,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $1.85 Million - $2.36 Million	-30,842 Reduced 77.76%	8,823 $674,000
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $1.07 Million - $1.39 Million	-22,278 Reduced 35.97%	39,665 $2.39 Million
Q3 2021 Nov 16, 2021	SELL	$54.64 - $61.3 $567,764 - $636,968	-10,391 Reduced 14.37%	61,943 $3.47 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $294,775 - $348,620	-4,981 Reduced 6.44%	72,334 $4.39 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $4.59 Million - $6.09 Million	77,315 New	77,315 $5.42 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Pacira Bio Sciences, Inc. Transaction History